CLINICAL_TRIALS
trial_result
· 2020-05-13
Clinical Trial Update: Sitagliptin Therapy and Kinetics of Inflammatory Markers [Phase 3]
Summary
Phase 3 trial investigating sitagliptin therapy and inflammatory marker kinetics in type 2 diabetes mellitus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Laval University | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2020-05-13